MD SB78 | 2026 | Regular Session

Status

Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on January 14 2026 - 25% progression
Action: 2026-01-21 - Hearing 2/12 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring certain providers and laboratories to provide certain written information to patients receiving prostate-specific antigen testing; and requiring clinical laboratories that administer prostate-specific antigen tests to follow certain disclosure requirements, use standard calibration for testing assays and report test results in a standard manner, make certain disclosures to ordering providers, and follow guidelines from certain organizations.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Public Health – Prostate–Specific Antigen Testing (Protect Our Prostate Act)

Sponsors


History

DateChamberAction
2026-01-21SenateHearing 2/12 at 1:00 p.m.
2026-01-20SenateHearing canceled
2026-01-19SenateHearing 1/27 at 2:30 p.m.
2026-01-14SenateFirst Reading Finance
2025-10-30SenatePre-filed

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Health - General17801(n/a)See Bill Text
Health - General17802(n/a)See Bill Text
Health - General17803(n/a)See Bill Text

Maryland State Sources


feedback